99 related articles for article (PubMed ID: 631191)
21. Beneficial effect of amosulalol and phentolamine on post-hypoxic recovery of contractile force and energy metabolism in rabbit hearts.
Tanonaka K; Matsumoto M; Minematsu R; Miyake K; Murai R; Takeo S
Br J Pharmacol; 1989 Jun; 97(2):513-23. PubMed ID: 2569344
[TBL] [Abstract][Full Text] [Related]
22. Effects of calcium ions and atropine on endotoxin-induced contractility deficit in rat atrial muscle.
Ashorobi RB; Kpohraror BO
East Afr Med J; 1995 Apr; 72(4):263-6. PubMed ID: 7621764
[TBL] [Abstract][Full Text] [Related]
23. The interaction between quinidine and propranolol on isolated heart muscle preparations.
Lameijer W; van Zwieten PA
Arch Int Pharmacodyn Ther; 1974 May; 209(1):10-3. PubMed ID: 4416330
[No Abstract] [Full Text] [Related]
24. Antiarrhythmic effects of solvents: II. Effects of propylene glycol and benzyl alcohol on the effective refractory period of isolated rabbit atria.
Yasake WJ; Eichbaum FW; Oga S
Cardiovasc Res; 1979 Dec; 13(12):711-6. PubMed ID: 534998
[TBL] [Abstract][Full Text] [Related]
25. Opposing regulatory influences of cyclic guanosine monophosphate and cyclic adenosine monophosphate in the control of cardiac muscle contraction.
George WJ; Busuttil RW; Paddock RJ; White LA; Ignarro LJ
Recent Adv Stud Cardiac Struct Metab; 1975; 8():243-50. PubMed ID: 175413
[TBL] [Abstract][Full Text] [Related]
26. Effects of flecainide and quinidine on human atrial action potentials. Role of rate-dependence and comparison with guinea pig, rabbit, and dog tissues.
Wang ZG; Pelletier LC; Talajic M; Nattel S
Circulation; 1990 Jul; 82(1):274-83. PubMed ID: 2114235
[TBL] [Abstract][Full Text] [Related]
27. Effects of atropine on atrial refractoriness and its dispersion in humans.
Michelucci A; Padeletti L; Fradella GA; Molina Lova R; Monizzi D; Giomi A; Fantini F
Int J Clin Pharmacol Ther Toxicol; 1984 May; 22(5):254-8. PubMed ID: 6746148
[TBL] [Abstract][Full Text] [Related]
28. Cardiac and vascular effects of NZ-105, a novel dihydropyridine derivative, in vitro.
Masuda Y; Iwama T; Yamashita T; Sakai T; Hibi M; Tanaka S; Shigenobu K; Kasuya Y
Arch Int Pharmacodyn Ther; 1991; 314():57-73. PubMed ID: 1668604
[TBL] [Abstract][Full Text] [Related]
29. Effect of quinidine on positive inotropic action of digoxin.
Williams JF; Mathew B
Am J Cardiol; 1981 May; 47(5):1052-5. PubMed ID: 7223650
[TBL] [Abstract][Full Text] [Related]
30. Effects of levomepromazine, chlorpromazine and their sulfoxides on isolated rat atria.
Dahl S; Refsum H
Eur J Pharmacol; 1976 Jun; 37(2):241-8. PubMed ID: 954807
[TBL] [Abstract][Full Text] [Related]
31. The clinical implication of changing unbound quinidine levels.
Kessler KM; Wozniak PM; McAuliffe D; Terracall E; Kozlovskis P; Mahmood I; Zaman L; Trohman RG; Castellanos A; Myerburg RJ
Am Heart J; 1989 Jul; 118(1):63-9. PubMed ID: 2741797
[TBL] [Abstract][Full Text] [Related]
32. Comparison between the tissue uptake of quinidine and its influence on the refractory period in isolated heart muscle.
Lameijer W; van Zwieten PA
Arch Int Pharmacodyn Ther; 1974 Aug; 210(2):321-32. PubMed ID: 4441197
[No Abstract] [Full Text] [Related]
33. Overdrive suppression of automaticity in cultured chick myocardial cells.
Pelleg A; Vogel S; Belardinelli L; Sperelakis N
Am J Physiol; 1980 Jan; 238(1):H24-30. PubMed ID: 7356031
[TBL] [Abstract][Full Text] [Related]
34. Electrophysiologic effects of atropine on human sinus node and atrium.
Dhingra RC; Amat-Y-Leon F; Wyndham C; Denes P; Wu D; Pouget JM; Rosen KM
Am J Cardiol; 1976 Oct; 38(4):429-34. PubMed ID: 184704
[TBL] [Abstract][Full Text] [Related]
35. Dose-response effects of quinidine on electrophysiological properties of the heart.
Duncan RJ; Nash CB
Arch Int Pharmacodyn Ther; 1972 Oct; 199(2):358-67. PubMed ID: 5070647
[No Abstract] [Full Text] [Related]
36. Effects of E4031 and quinidine on atrial and ventricular refractoriness in rabbits in vivo.
Chan AP; Leung MW; So PP; Guppy LJ; Walker MJ
Proc West Pharmacol Soc; 2004; 47():39-41. PubMed ID: 15633608
[TBL] [Abstract][Full Text] [Related]
37. Pharmacologic conversion and suppression of experimental canine atrial flutter: differing effects of d-sotalol, quinidine, and lidocaine and significance of changes in refractoriness and conduction.
Feld GK; Venkatesh N; Singh BN
Circulation; 1986 Jul; 74(1):197-204. PubMed ID: 3708774
[TBL] [Abstract][Full Text] [Related]
38. Neuropeptide Y is a prejunctional inhibitor of vagal but not sympathetic inotropic responses in guinea-pig isolated left atria.
Serone AP; Angus JA
Br J Pharmacol; 1999 May; 127(2):383-90. PubMed ID: 10385237
[TBL] [Abstract][Full Text] [Related]
39. Voltage- and time-dependent inhibitory effects on rat aortic and porcine coronary artery contraction induced by propafenone and quinidine.
Pérez-Vizcaíno F; Fernández del Pozo B; Zaragozá F; Tamargo J
Br J Pharmacol; 1994 Dec; 113(4):1281-8. PubMed ID: 7889284
[TBL] [Abstract][Full Text] [Related]
40. Mechanism of action of quinidine on heart rate in the dog.
Chassaing C; Duchene-Marullaz P; Paire M
J Pharmacol Exp Ther; 1982 Sep; 222(3):688-93. PubMed ID: 6286932
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
